The forecast for insulin imports to India shows a declining trend from 2024 to 2028. In 2023, actual import values were higher compared to forecasted values in subsequent years. The year-on-year variations from 2024 onward indicate a consistent downward trend in import values. Over this period, the compound annual growth rate (CAGR) reflects a negative average variation, underscoring a reduction in imports.

Future trends to watch for:

Improvement in domestic insulin production could reduce reliance on imports.
Policy changes and healthcare reforms in India could impact import volumes.
Evolving global market dynamics and trade agreements influencing India's import decisions.